 BOSTON , March 9, 2022 PRNewswire -- Stealth BioTherapeutics Corp Nasdaq:MITO, a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial dysfunction, today announced that Reenie McCarthy, CEO, will present at three upcoming investor conferences in March: Oppenheimer 32nd Annual Healthcare Conference. Pre-recorded presentation available for on-demand viewing starting on Tuesday, March 15 at 4:40 p.m. 